SCHEMBL6589644

SCHEMBL6589644

CC(C)(C)OC(=O)N1CC[C@@H]1COc1cncc(-c2ccsc2)c1

nearest known ligand 0.42

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 16/20 0.42
CHRNB4 P30926 16/20 0.42
CHRNA3 P32297 16/20 0.42
CHRNB1 P11230 15/20 0.42
CHRNB3 Q05901 15/20 0.42
GPR119 Q8TDV5 1/20 0.42
CHEK2 O96017 1/20 0.39
CHRNA4 P43681 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6585505 0.86 CHRNB2 (0.58) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL6587447 0.86 CHRNB2 (0.56) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL6583951 0.84 CHRNB1 (0.61) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL6583208 0.82 CHRNB1 (0.61) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL7465912 0.82 CHRNB2 (0.57) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL7923228 0.81 CHRNB1 (0.46) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL14216678 0.81 TLR7 (0.36) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL14779759 0.81 CYP11B1 (0.55) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL14779765 0.81 CYP11B1 (0.55) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3
SCHEMBL3357256 0.81 CHRNB2 (0.44) CHRNB2CHRNB4CHRNA3CHRNB1CHRNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934308-B1 3-PYRIDYLOXYMETHYL HETEROCYCLIC ETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION ABBOTT LAB (US) 2004-08-11 EP disclosed
US-6127386-A STIMULANTS, NEUROTRANSMITTERS, CHOLINERGIC AGENTS ABBOTT LABORATORIES (US) 2000-10-03 US disclosed
US-5629325-A TREATMENT OF NERVOUS SYSTEM DISORDERS; NEURONAL NICOTINIC CHOLINERGIC COMPOUNDS ABBOTT LABORATORIES (US) 1997-05-13 US disclosed